Trial Profile
A Phase II Study of Decitabine in Patients With Chronic Myelomonocytic Leukemia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Decitabine (Primary)
- Indications Chronic myelomonocytic leukaemia
- Focus Therapeutic Use
- 28 Nov 2011 Actual end date (Jun 2009) added as reported by ClinicalTrials.gov.
- 28 Nov 2011 Actual initiation date (Nov 2008) added as reported by ClinicalTrials.gov.
- 07 Apr 2010 New trial record